55 related articles for article (PubMed ID: 29271560)
1. Calculating individualized glycaemic targets using an algorithm based on expert worldwide diabetologists: Implications in real-life clinical practice.
Alvarez-Guisasola F; Cebrián-Cuenca AM; Cos X; Ruiz-Quintero M; Millaruelo JM; Cahn A; Raz I; Orozco-Beltrán D;
Diabetes Metab Res Rev; 2018 Mar; 34(3):. PubMed ID: 29271560
[TBL] [Abstract][Full Text] [Related]
2. Assessing Diabetes Self-Management with the Diabetes Self-Management Questionnaire (DSMQ) Can Help Analyse Behavioural Problems Related to Reduced Glycaemic Control.
Schmitt A; Reimer A; Hermanns N; Huber J; Ehrmann D; Schall S; Kulzer B
PLoS One; 2016; 11(3):e0150774. PubMed ID: 26938980
[TBL] [Abstract][Full Text] [Related]
3. Determinants of sub-optimal glycemic control among patients enrolled in a medicine dispensing programme in KwaZulu-Natal: A cohort study, 2018-2021.
Johnston LC; Ngassa Piotie P; Maposa I; Singh S; Kuonza L; De Voux A
Afr J Prim Health Care Fam Med; 2024 May; 16(1):e1-e12. PubMed ID: 38832377
[TBL] [Abstract][Full Text] [Related]
4. The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data.
Hellgren M; Svensson AM; Franzén S; Ericsson Å; Gudbjörnsdottir S; Ekström N; Bertilsson R; Valentine W; Malkin S
Diabetes Obes Metab; 2021 Jul; 23(7):1604-1613. PubMed ID: 33729661
[TBL] [Abstract][Full Text] [Related]
5. Clinical Assessment of Individualized Glycemic Goals in Patients With Type 2 Diabetes: Formulation of an Algorithm Based on a Survey Among Leading Worldwide Diabetologists.
Cahn A; Raz I; Kleinman Y; Balicer R; Hoshen M; Lieberman N; Brenig N; Del Prato S; Cefalu WT
Diabetes Care; 2015 Dec; 38(12):2293-300. PubMed ID: 26519337
[TBL] [Abstract][Full Text] [Related]
6. Glycaemic Control for People with Type 2 Diabetes Mellitus in Bangladesh - An urgent need for optimization of management plan.
Afroz A; Ali L; Karim MN; Alramadan MJ; Alam K; Magliano DJ; Billah B
Sci Rep; 2019 Jul; 9(1):10248. PubMed ID: 31308457
[TBL] [Abstract][Full Text] [Related]
7. Demographic, social and geographic factors associated with glycaemic control among US Veterans with new onset type 2 diabetes: a retrospective cohort study.
Lee DC; Orstad SL; Kanchi R; Adhikari S; Rummo PE; Titus AR; Aleman JO; Elbel B; Thorpe LE; Schwartz MD
BMJ Open; 2023 Oct; 13(10):e075599. PubMed ID: 37832984
[TBL] [Abstract][Full Text] [Related]
8. Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis.
Sadeghi A; Bayazidi Y; Davari M; Kebriaeezadeh A; Assarian A; Esteghamati A; Yousefi S
Iran J Med Sci; 2023 May; 48(3):286-291. PubMed ID: 37791332
[TBL] [Abstract][Full Text] [Related]
9. The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review.
Westall SJ; Narayanan RP; Watmough S; Irving G; Furlong N; McNulty S; Bujawansa S; Hardy K
Clin Med (Lond); 2022 May; 22(3):257-265. PubMed ID: 35443970
[TBL] [Abstract][Full Text] [Related]
10. Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis.
Pettit S; Cresta E; Winkley K; Purssell E; Armes J
PLoS One; 2017; 12(5):e0176941. PubMed ID: 28467470
[TBL] [Abstract][Full Text] [Related]
11. [Checklist for patients with type 2 diabetes mellitus for remote consultation].
Angullo-Martínez E; Carretero-Anibarro E; Sánchez Barrancos IM; Cos Claramunt X; Orozco Beltrán D; Torres Baile JL; Ezkurra Loiola P; ;
Aten Primaria; 2021 Apr; 53(4):101983. PubMed ID: 33743202
[TBL] [Abstract][Full Text] [Related]
12. Will 'Computable' Clinical Guidelines Be Compatible with Personalised Care?
Dowie J; Kaltoft MK; Rajput VK
Stud Health Technol Inform; 2024 Apr; 313():192-197. PubMed ID: 38682529
[TBL] [Abstract][Full Text] [Related]
13. Glycaemic index as part of the diabetes prevention strategy.
Frost G
Lancet Diabetes Endocrinol; 2024 May; 12(5):289-290. PubMed ID: 38588685
[No Abstract] [Full Text] [Related]
14. Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus.
Bannister M; Berlanga J
Diabetes Ther; 2016 Sep; 7(3):387-99. PubMed ID: 27502496
[TBL] [Abstract][Full Text] [Related]
15. Remission of Type 2 Diabetes: Diabetes Canada Clinical Practice Guidelines Expert Working Group.
MacKay D; Chan C; Dasgupta K; Dominy C; Gagner M; Jin S; Kim J; Little JP; MacDonald B; McInnes N; Reichert S; Bajaj HS; ; Bajaj HS; Gilbert J; Houlden R; Kim J; MacDonald B; MacKay D; Mansell K; Rabi D; Senior P; Sherifali D
Can J Diabetes; 2022 Dec; 46(8):753-761.e8. PubMed ID: 36567079
[No Abstract] [Full Text] [Related]
16. Editorial: Nutritional status in disease: development, evaluation, prognosis and individualized treatment in clinical practice.
Sang W
Front Nutr; 2023; 10():1292777. PubMed ID: 37876613
[No Abstract] [Full Text] [Related]
17. [Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS].
Orozco-Beltrán D; Brotons Cuixart C; Banegas Banegas JR; Gil Guillén VF; Cebrián Cuenca AM; Martín Rioboó E; Jordá Baldó A; Vicuña J; Navarro Pérez J
Aten Primaria; 2022 Oct; 54 Suppl 1(Suppl 1):102444. PubMed ID: 36435583
[TBL] [Abstract][Full Text] [Related]
18. Glycemic variability and all-cause mortality in a large prospective southern European cohort of patients with differences in glycemic status.
Salinero-Fort MA; San Andrés-Rebollo FJ; Cárdenas-Valladolid J; Mostaza JM; Lahoz C; Rodriguez-Artalejo F; Gómez-Campelo P; Vich-Pérez P; Jiménez-García R; López de Andrés A; de Miguel-Yanes JM;
PLoS One; 2022; 17(7):e0271632. PubMed ID: 35877766
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular preventive recommendations. PAPPS 2020 update].
Orozco-Beltrán D; Brotons Cuixart C; Alemán Sánchez JJ; Banegas Banegas JR; Cebrián-Cuenca AM; Gil Guillen VF; Martín Rioboó E; Navarro Pérez J
Aten Primaria; 2020 Nov; 52 Suppl 2(Suppl 2):5-31. PubMed ID: 33388118
[TBL] [Abstract][Full Text] [Related]
20. Trends in HbA
Ambrož M; de Vries ST; Hoogenberg K; Denig P
Pharmacoepidemiol Drug Saf; 2021 Jan; 30(1):37-44. PubMed ID: 32955156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
